Asian J Psychiatr 2017 Dec 1;30:120-121. Epub 2017 Sep 1.

Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala, India. Electronic address:

Download full-text PDF

Source Listing
December 2017
5 Reads

Publication Analysis

Top Keywords

syndrome nms
malignant syndrome
neuroleptic malignant
atypical neuroleptic

Similar Publications

[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].

Encephale 2016 Jun 26;42(3):277-80. Epub 2016 Feb 26.

Pôle Santé Publique, Pharmacovigilance, CHU Grenoble-Alpes, 38000 Grenoble, France.

Background: Neuroleptic malignant syndrome (NMS) is an uncommon but potentially fatal adverse effect of neuroleptic drugs. It is commonly characterized by muscular rigidity, fever, altered mental status, and autonomic dysfunction. Emerging of NMS is possible with all neuroleptics, classic and atypical. Read More

View Article
June 2016

Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.

Int J Psychiatry Med 2015 ;49(1):35-43

Tsyr-Huey Mental Hospital, Kaohsiung Jen-Ai's Home, Taiwan

Objectives: Neuroleptic malignant syndrome (NMS) requires emergency treatment and can be fatal. Combined aripiprazole and clozapine therapy is rarely used in clinical settings, and NMS related this combination still lacks evaluation. Herein, we present two cases of atypical NMS treated with aripiprazole and clozapine. Read More

View Article
September 2015

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Encephale 2008 Dec 2;34(6):618-24. Epub 2008 Apr 2.

Background: Neuroleptic malignant syndrome (NMS) is an uncommon, but potentially life threatening complication of neuroleptic drugs. In 1960, Delay et al. [Ann Med Psychol 118 (1960) 145-152] described the "syndrome akinétique hypertonique"(hypertonic akinetic syndrome) and its cardinal symptoms: hyperthermia, extrapyramidal symptoms, altered mental status and autonomic dysfunctions. Read More

View Article
December 2008

[Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].

Fortschr Neurol Psychiatr 1993 Jun;61(6):217-22

Psychiatrische Klinik, Universität Würzburg.

Clozapine is an atypical neuroleptic drug characterised by a striking lack of extrapyramidal side effects. Although these features would seem to make clozapin an unlikely agent for the induction of neuroleptic malignant syndrome (NMS), several putative clozapin-related cases of NMS have recently been reported. A reevaluation of these articles raised some doubts on the causal relationship between clozapin therapy and NMS in most cases. Read More

View Article
June 1993